Hans E. Bishop

2016

In 2016, Hans E. Bishop earned a total compensation of $3.8M as President, Chief Executive Officer and Director at Juno Therapeutics, a 29% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$200,000
Option Awards$3,069,500
Salary$483,894
Total$3,753,394

Bishop received $3.1M in option awards, accounting for 82% of the total pay in 2016.

Bishop also received $200K in non-equity incentive plan and $483.9K in salary.

Rankings

In 2016, Hans E. Bishop's compensation ranked 2,428th out of 14,075 executives tracked by ExecPay. In other words, Bishop earned more than 82.7% of executives.

ClassificationRankingPercentile
All
2,428
out of 14,075
83rd
Division
Manufacturing
839
out of 5,486
85th
Major group
Chemicals And Allied Products
244
out of 1,900
87th
Industry group
Drugs
178
out of 1,543
89th
Industry
Biological Products, Except Diagnostic Substances
37
out of 287
87th
Source: SEC filing on April 21, 2017.

Bishop's colleagues

We found four more compensation records of executives who worked with Hans E. Bishop at Juno Therapeutics in 2016.

2016

Steven Harr

Juno Therapeutics

Chief Financial Officer

2016

Hyam Levitsky

Juno Therapeutics

Chief Scientific Officer

2016

Robert Azelby

Juno Therapeutics

Executive Vice President, Chief Commercial Officer

2016

Bernard Cassidy

Juno Therapeutics

General Counsel

In-depth

You may also like